Mr. Hermes Chan reports

MEDMIRA ANNOUNCES PARTNERSHIP WITH MEDIGROUP PHYSICIAN SERVICES IN THE UNITED STATES

Medmira Inc. has entered a partnership with MediGroup, a leader in the U.S. health care industry since 1999. This new partnership allows the company to promote and sell its products to over 44,000 existing customers.

MediGroup is the United States' largest group purchasing organizations for physician offices, surgery centres and specialty clinics. MediGroup focuses on providing over 250,000 health care employees the best prices and provides predictable cost containment, enhancing physicians' purchasing power so they can benefit from hospital-like discounts and access to the best products and services. The company offers access to trusted quality manufacturers, and provides a comprehensive portfolio to its clients from medical supplies, pharmaceuticals and laboratory supplies.

"We are excited to work with MediGroup and its vast network of clients. This partnership enables over 44,000 existing customers to gain access to our products and enjoy the best possible pricing. With the great support by MediGroup's team, we can not only grow in this field with our products, [but also] offer the best service in terms of supply," said Hermes Chan, chief executive officer of Medmira. "We are impressed with the significant footprint MediGroup has built in this industry and are delighted at the flexible and creative approach to inform and market products to their members."

"Over the past 20-plus years, MediGroup has grown to provide our members with the most comprehensive contract portfolio that maximizes efficiencies and minimizes costs," said MediGroup's chief executive officer, Andy Klearman. "We know our members will value, too, the Medmira solution and pricing."

The partnership with MediGroup allows Medmira to gain access to vast amount of health care providers and, with it, offer its unique quality products. As a first step, the company offers its Reveal G4 HIV-1/2 antibody rapid test, the world's fastest HIV rapid test. Based on Medmira's patented rapid vertical flow technology, the Reveal G4 HIV offers a simple testing solution with immediate results which do not fade away, therefore, offering the best rapid testing solution to MediGroup's members, which is Food and Drug Administration approved since 2001. The Reveal G4 HIV is offered in three convenient formats (point of care, laboratory format serum/plasma and venipuncture whole blood) to accommodate any health care setting. With its unique in-build procedural and reagent control line, an operator can be assured that each test has been performed correctly.

A unique feature of Medmira's patented technology is the elimination of the pro-zone (hook) effect, a known challenge in serological testing, where a high concentration of antibodies can lead to false-negative results. Medmira's rapid vertical flow technology eliminates this risk by ensuring that the antibody binding takes place in a controlled, localized environment before visualization. Any excess antibodies are washed away, preventing interference and ensuring accurate detection. This makes any test highly reliable for both low- and high-antibody levels, eliminating the risk of false-negative results.

About Medmira Inc.

Medmira is a leading developer and manufacturer of rapid vertical flow diagnostics. The company's tests provide hospitals, labs, clinics and individuals with instant disease diagnosis, such as HIV, syphilis, hepatitis and SARS-CoV-2 in just three easy steps. The company's tests are sold globally under the Reveal, Multiplo and Miriad brands. Based on its patented rapid vertical flow technology, Medmira's rapid HIV test is the only one in the world to achieve regulatory approvals in Canada, the United States, China and the European Union. Medmira's corporate offices and manufacturing facilities are located in Halifax, N.S., Canada.

We seek Safe Harbor.